COVID-19
FHI 360 has been responding to the COVID-19 pandemic since the earliest days of the pandemic: facilitating COVID-19 vaccine and treatment trials, developing remote learning plans and socio-emotional support systems for children and youth, and leveraging our HIV and TB programs in more than 40 countries to support countrywide COVID-19 treatment and response, and much more.
As the COVID-19 pandemic evolves, we continue to work with our partners to control and respond to the pandemic, while gathering the knowledge we have gained during this crisis to help prevent the next one. We work in more than 60 countries to strengthen COVID-19 clinical care at all levels of the health system, increase access to medical oxygen, support global vaccination efforts, bolster health systems, and address the mental health and psychosocial support needs of healthcare workers and patients. FHI 360 partners with national and subnational governments, health facility leaders, the private sector, national laboratories, academic partners and professional clinical associations, civil society organizations and community-based organizations to support national and global COVID-19 responses.
FHI 360 offers capabilities and technical expertise related to epidemic prevention and preparedness, detection and response. These capabilities — combined with our broad expertise in working with multiple partners and enabled by our family of companies and global footprint — make FHI 360 uniquely positioned to support the COVID-19 response.
FHI 360 supports national COVID-19 response in more than 60 countries through several projects, including (but not limited to) the following:
FHI 360
@FHI 360